Genevieve Spota

Nurse Practitioner - Adult Health

Genevieve Spota is a Staten Island, New York based nurse practitioner who is specialized as Adult Health nurse. Her current practice location is 130 Rose Ave, Staten Island. Patients can reach her at 718-980-1553 with specialization in Adult Health and her NPI number (Unique professional ID assigned by NPPES) is 1003214628.
Genevieve Spota can evaluate, diagnose patients overall wellness, and conditions such as cancer, heart disease, diabetes, arthritis, sports injuries, and other ailments. She can see patients and promote healthy living and wellness. She can perform physical examinations, order and interpret tests, prescribe medications and treatments, and can also provide education and counseling to patients on wellness strategies and disease prevention.

Complete Profile:
Genevieve Spota speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Genevieve Spota
Specialization: Adult Health Nurse Practitioner (ANP)
Gender:Female
Practice Address:130 Rose Ave, Staten Island,
New York, 10306-2241
Phone:718-980-1553
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1003214628
NPI Enumeration Date: 13 Dec, 2014
NPI Last Update On: 13 Dec, 2014

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Genevieve Spota
130 Rose Ave,
Staten Island, New York
Zip: 10306-2241
Patients can reach Genevieve Spota at 130 Rose Ave, Staten Island, New York or can call to book an appointment on 718-980-1553.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.